Title:  The New Generation of Cerebral Aneurysm Therapy

Speaker: Claire Houston, Clinical Consultant for Pulsar Vascular

Date:  06/05/2018

Brief Description:
This program covered intracranial aneurysms and challenges associated with these difficult to treat lesions. Historically intracranial aneurysms were treated with open surgery but after 2003, embolic coiling became the preferred method of treatment. There have been significant advances regarding the use, safety, and efficacy of these devices however, these
lesions remain difficult to treat for the endovascular surgeon. Specifically, this program covered the multitude of requirements it takes to bring a novel product to market to replace or improve on the minimally invasive device currently available in the US and Europe.

Attachment:

To see this content, please login

Title: Transforming the dental implant into a bio-engineered medical device

Speaker: Issa Karkar, DDS, CEO In Pronto

Date: 05/08/2018

Brief Description:
InPronto has removed the current fundamental disconnection in the process between implant surgery and the prosthetic fabrication and placement which may not function as intended might provide inferior results, and instead solves it holistically treating the tooth as complete device, from the root tip to the cusp tip, as nature intended it and thus delivering superior results. InPronto creates a paradigm shift transforming the dental implant into a medical device and simplifying the delivery process

Attachment:

To see this content, please login

Title: Deep learning and its application in Medicine

Speaker: Ravi Chityala, Senior Engineer, Elekta

Date:  04/03/2018

Brief Description:
In the last 10 years, much progress has been made with Neural Networks and Deep Learning due to accelerated computer power (GPUs) and availability of Open Source libraries. This talk will delve into some of these technologies and how they help accelerate.

Attachment:

To see this content, please login

Title: Wearable Devices from Idea to FDA Approval

Author: Walt Maclay – President, Voler Systems

Date: 03/13/2018

Brief Description:
Walt Maclay discussed the issues involved with bringing wearable medical devices from an idea to FDA approval. He discussed areas including different sensing technologies, battery life, data security, and meeting FDA and CE requirements.

Attachment:

To see this content, please login

Title: Overcoming hurdles developing neuroprotective drugs

Author: Marcel Alavi, Founder of 712 North

Date: 02/27/2018

Brief Description:
712 North is a biopharma developing medical interventions for patients with Alzheimer’s and other forms of dementia. Medicines currently available for this devastating disease only treat the cognitive symptoms, but do not affect the underlying causes of the disorder. We identified a novel mechanism-of-action that can complement all existing efforts to treat Alzheimer’s by studying a rare eye disease called Autosomal Dominant Optic Atrophy. We strongly believe, and as a matter of fact we have the data to support this claim, that whatever helps patients with ADOA will help patients with Alzheimer’s disease as well.

Attachment:

To see this content, please login

Title: SenSonic – The World Debut of the “Neckband Style” Self-Programmable, Wireless Hearing Aid

Speaker: Asela Udhaya Bandara Jayampathy, Co-Founder and CEO BioSound

Date: 02/13/2018

Brief Description:
SenSonic is the world’s only hearing aid capable of user-configurable audiometric measurement and shift-on-the-fly reprogramming when the wearer moves from one environment to another. This is a revolutionary step towards empowering wearers with self-programmable hearing aids that do not require the intervention of an audiologist.
1) SenSonic Neckband Hearing Aid has the widest distance between Microphones and Receivers eliminating the need to have an
acoustic feedback cancellation algorithm which compromises speech amplification.
2) Wireless Ear Sets with Interchangeable Receivers tuned to hear speech or hi-resolution music.

Attachment:

To see this content, please login

Title: Rising Obesity in America, with the primary focus on childhood obesity.

Speaker: Anamika Sharma, MD

Date:  01/30/2018

Brief Description:
Rising problem of obesity in America with primary focus on childhood obesity. Dr. Sharma talked about prevention and different options of medical treatment with discussion of few FDA approved medicines and patients screening, assessment for surgical treatments.

Attachment:

To see this content, please login

Title: From Condoms to Brain Implants: Protecting Patient Safety Across the Device Spectrum Through Biological Assessment

Speakers: Thor Rollins, Audrey Turley

Date: 12/05/2017

Brief Description:
Using a risk-based approach to address biocompatibility has become mainstream, and actively encouraged by the FDA. This strategy allows manufacturers to leverage previous testing knowledge of device materials and chemistry to reduce their testing burden while improving patient safety. The caveat? Manufacturers have to better understand their materials and how they interact with the body.

Attachment:

To see this content, please login

Title: Sprout Medical, Making an Impact in Critical Care

Speaker: Jerry Gibson, CEO, Sprout Medical

Date: 11/14/2017

Brief Description:
Sprout Medical has developed a cost-effective system to increase the clinical efficiency of administrating the rapid infusion of
various fluids that are so important in the treatment of sepsis, trauma and other critical conditions in the ED, ICU, OR and prehospital
environments. Mr. Gibson will review the clinical and competitive landscape as well as Sprout Medical’s approach to
tackling this important issue.

Attachment:

To see this content, please login

Title: Disrupting the Standard of Care Through the Novel Combination of Wearable Devices and Data Analytics

Speaker: Justin Cambra, Senior Director of Systems Development, iRhythm

Date: 10/24/2017

Brief Description:
Justin Cambra’s talk will review how iRhythm Technologies is disrupting the standard of care in diagnosing cardiac arrhythmias through the Zio Patch, Machine-Learned Algorithms, and data analysis. It will cover successes, challenges, and lessons learned utilizing data to grow and scale the diagnostic service.

Attachment:

To see this content, please login